Serina Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold SER, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$80366
Total value held
Buying
6 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $40296 | 20771 | +20771 | NEW BUY |
| 2 | State Street Corp | $24751 | 12758 | — | Held |
| 3 | Wells Fargo & Company/Mn | $7006 | 3611 | +5 | +0.14% |
| 4 | Blackrock, Inc. | $4613 | 2378 | -55886 | -95.92% |
| 5 | Ubs Group Ag | $2613 | 1347 | +1347 | NEW BUY |
| 6 | Barclays Plc | $1057 | 545 | +545 | NEW BUY |
| 7 | Morgan Stanley | $28 | 14 | +6 | +75.00% |
| 8 | Jpmorgan Chase & Co | $2 | 1 | +1 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.